Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade

Sebastian R. Nielsen(University of Copenhagen), Janine T. Erler(Cancer Research UK)
Nature Communications
June 7, 2021
Cited by 120


Related Papers